Clinical Trial

SALACIA: SALvesAn vs Conventional Management of dIAbetic Foot Wounds

Study acronym: SALACIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 3, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Increasing prevalence of diabetes mellitus has led to increasing numbers of chronic non-healing foot ulcers (wounds). Electrolysed water is a novel antiseptic which reduces bacterial load and appears to encourage wound healing. The investigators propose to compare electrolysed water against conventional management.
Trial Details
NCT Number NCT06908148
Lead Sponsor NHS Lanarkshire
Conditions Foot Ulcers, Diabetic, Foot Ulcer Unhealed
Enrollment 200 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-03